Danirixin Size:5mg

Danirixin Size:5mgDescription Danirixin (GSK1325756) is an orally active, selective CXC chemokine receptor 2 (CXCR2) antagonist with 78 fold lower affinity toward CXCR1 (CXCR2 CXCR1 IC50 = 12. 5 977 nM by competitive binding against 0. 225 nM [125I] CXCL8). Danirixin blocks agonist induced neutrophil CD11b expression in vitro (IC50 = 420 890 nM against induction by 10 nM human CXCL1 rat CXCL2 using rat human whole blood) and prevents lung neutrophils influx in rats in

Blood Bank Configuration On Casters Number of Doors 1-Door Protection Level Anti-corrosion Other Characteristics Stainless Steel

Using three-axis gyroscope to monitor the balance of the whole dynamic state

wash it thoroughly with water

P100167-WB-1-P

there are at least erythrocytes equivalent to those contained in 15 ml of blood

Availability of auto-restart function in case of power loss for overnight operations

Swissprot No O75461 Gene Accession BC008348 WB Predicted band size 32 kDa WB Positive control WB Recommended dilution 500-2000 IHC predicted cell location Predicted cell location: Cytoplasm IHC positive control Positive control: Human cervical cancer IHC Recommed dilution Recommended dilution: 100-300 Storage

and robust safety protections

Measure about 500 ml of pure water

stable performance

Beta-hexosaminidase is composed of two subunits

Mini HCL100 with hot lid provided topreserve the generated heat